Do Preprints Exaggerate Their Results?

Published Date: 22 Apr 2023

A recent study found that preprints provide spin in addition to new science. F. remarks made by Perry Wilson.

Read Full News

Latest News

Medscape Physician Wealth & Debt Report 2026

Physicians reveal how well their incomes help build family net worth, as well as investment and spending philosophies. Wealth disparities are reported by gender and race.

Can Fasting Reprogram Chronic Pain?

Therapeutic fasting offers a metabolic approach to chronic pain by shifting to fat metabolism, reducing systemic inflammation, and modulating central sensitization.

Medscape Most Popular Specialties for Doctors Report 2026

As physicians navigate the subsidy expirations and new efficiency mandates, which specialties do doctors feel are most and least appealing?

‘Laughing Gas’ for TRD: What Does the Research Say?

Emerging evidence suggests nitrous oxide provides rapid relief for treatment-resistant depression. But is the therapy ready for the clinic?

Patients Sue Two More Health Systems Over AI Scribe Use

Months after a lawsuit against a San Diego health system, another class action alleges two more California health systems used Abridge’s AI tool to record patient visits without consent.

US FDA to Convene Expert Panel to Review Wider Access to Some Peptides

The U.S. Food and Drug Administration will convene a panel of outside advisers in July to ⁠consider whether licensed compounding pharmacies should be allowed to manufacture...

Todays Updates

CAR-T Induces Deep, Durable Remission in Smoldering Myeloma

In a pilot study — the first to test CAR-T therapy in smoldering multiple myeloma — patients with high-risk disease remained MRD-negative for more than 15 months. But is it a cure?

‘Bar Code’ Biopsy From RNA Could Guide Precision Oncology

New research shows how certain orphan noncoding RNA — oncRNA — can be predictable enough to be a ‘bar code’ identifying specific cancers. Liquid biopsy could be next.

Dasatinib Fails to Improve Outcomes in CBF-AML

A phase 3 study investigates the outcomes associated with intensive chemotherapy with or without dasatinib in core-binding factor acute myeloid leukemia.

CD39 Blockade Shows Potential in Early-Stage Lung Cancer

A single-arm study hints at an uptick in pathologic complete responses when a CD39 blocker is added to perioperative durvalumab and chemotherapy for NSCLC.

Measurable Residual Disease Predicts Real-World AML Relapse

A study of a real-world population underscores measurable residual disease thresholds indicative of the risk for relapse in NPM1-mutated AML, suggesting guidance in treatment decisions.

Todays Updates

CAR-T Induces Deep, Durable Remission in Smoldering Myeloma

In a pilot study — the first to test CAR-T therapy in smoldering multiple myeloma — patients with high-risk disease remained MRD-negative for more than 15 months. But is it a cure?

‘Bar Code’ Biopsy From RNA Could Guide Precision Oncology

New research shows how certain orphan noncoding RNA — oncRNA — can be predictable enough to be a ‘bar code’ identifying specific cancers. Liquid biopsy could be next.

Dasatinib Fails to Improve Outcomes in CBF-AML

A phase 3 study investigates the outcomes associated with intensive chemotherapy with or without dasatinib in core-binding factor acute myeloid leukemia.

CD39 Blockade Shows Potential in Early-Stage Lung Cancer

A single-arm study hints at an uptick in pathologic complete responses when a CD39 blocker is added to perioperative durvalumab and chemotherapy for NSCLC.

Measurable Residual Disease Predicts Real-World AML Relapse

A study of a real-world population underscores measurable residual disease thresholds indicative of the risk for relapse in NPM1-mutated AML, suggesting guidance in treatment decisions.

Latest News

Physicians reveal how well their incomes help build family net worth, as well as investment and spending philosophies. Wealth disparities are reported by gender and race.

Therapeutic fasting offers a metabolic approach to chronic pain by shifting to fat metabolism, reducing systemic inflammation, and modulating central sensitization.

As physicians navigate the subsidy expirations and new efficiency mandates, which specialties do doctors feel are most and least appealing?

Emerging evidence suggests nitrous oxide provides rapid relief for treatment-resistant depression. But is the therapy ready for the clinic?

Months after a lawsuit against a San Diego health system, another class action alleges two more California health systems used Abridge’s AI tool to record patient visits without consent.

The U.S. Food and Drug Administration will convene a panel of outside advisers in July to ⁠consider whether licensed compounding pharmacies should be allowed to manufacture...

News All Time

Medscape Physician Compensation Report 2026: Positive Signs

US physicians report their 2025 compensation and satisfaction with it. Differences in doctor pay by gender, racial and ethnic group, and medical specialty are revealed.

Lidocaine Combo Therapy Promising in Hemorrhoidal Disease

A regimen combining oral flavonoids and bromelain with topical lidocaine is linked to better symptom improvement and outcomes in acute hemorrhoidal disease.

New Central Sleep Apnea Guidelines: Did They Go Too Far?

In this analysis, Dr Aaron Holley examines new sleep apnea guidelines that revive CPAP and ASV in heart failure — and questions whether signals of harm are being overlooked.

The Pitt Season 2: EM Docs Rate Its Accuracy (Part 2)

Airway hacks, bias at the bedside, and hospital cyberattacks — Drs Robert Glatter and Amy Faith Ho unpack the most intense cases from The Pitt, season 2, and the realities behind them.

Novel Opioid Offers Pain Relief Without Classic Side Effects

A novel mu-opioid receptor agonist showed strong analgesia without respiratory depression, tolerance, or significant addiction signals in animal models.

U.S. Health Officials Warn Of Veterinary Sedative in Illegal Drug Supply

The Centers for Disease Control and Prevention on Thursday issued a health advisory warning of rising ⁠reports from U.S. jurisdictions detecting veterinary sedative...

From Burnout to Travel: Doctors’ Retirement Choices

Nearly 3000 physicians across Argentina, Brazil, and Mexico reveal how burnout, finances, and professional identity are reshaping when and how they plan to leave clinical practice.

Pericapsular Nerve Block Shows Modest Benefit in Hip Surgery

A preoperative pericapsular nerve group vs sham block shows modest benefits in hip arthroscopy, with a shorter postanesthesia care unit stay, but does not improve the recovery quality at 24 hours.

British Plan to Legalise Assisted Dying Falters in Parliamentary Tug-of-war

Eighty-year-old Suzie Jee was elated when Britain's lower house of parliament voted to legalise assisted dying nine months ago. Suffering from incurable bone cancer, she...

Does Ibuprofen Increase the Risk for Empyema?

To understand the rise in complicated pneumonia, we must take a closer look at the evidence linking ibuprofen to empyema risk.

Anesthetic Risk Linked to Venezuelan Maternal Lineage

Reports link a mitochondrial MT-ND4 variant (m.11232T>C) to severe neurologic injury after sevoflurane in patients with Venezuelan maternal ancestry, prompting international alerts.

Simple Grip Test Can Predict Independence Loss Post-Surgery

Low preoperative grip strength can be a useful screening tool for predicting postoperative loss of independence in older adults undergoing hepatobiliary-pancreatic surgery.

Bullish Optimism on AI and the Physician’s Role in Medicine

Drs Bob Harrington and Bob Wachter discuss the use of AI in healthcare, and Dr Wachter’s latest book, A Giant Leap.

Physicians Must Lead AI Integration in Medicine

It's no longer a question that AI will shape the future of medicine. But it must be accountable and transparent, and physicians must lead its integration into clinical practice, writes AMA's CEO, John Whyte, MD, MPH.

Cuban Doctors Endure Burnout, Blackouts as Healthcare Declines

A Cuban doctor with more than 25 years of practicing medicine, like most Cubans drawing a government salary, needs a side hustle to get by.

Remimazolam Tosylate Matches Propofol for ICU Sedation

Remimazolam tosylate is as effective as propofol for sedation in patients on mechanical ventilation in the ICU, a phase 3 trial finds.

Recommended News For You

Since 2000, the outlook for multiple myeloma has improved.

A novel blood test may enable the early identification of common, fatal cancers.

Durvalumab Wins FDA Approval in Limited-Stage SCLC

Telisotuzumab vedotin shows durable response in some Asian patients with nonsquamous NSCLC

Ketamine plus psychotherapy for "excellent" PTSD

Hereditary cancer has a rare and underreported cause.

Dissociative identity disorder: method or fact?

Recommended Articles For You

The Evolving Arsenal: A 2025 Review of Antibody-Drug Conjugates and the Future of Precision Oncology 

The Latest Research on Wiskott Aldrich Syndrome  

Bridging Heart and Cancer Care: The Essential Framework of a Modern Cardio-Oncology Program 

Revolutionizing Lung Transplantation: The Promise of Donor-Specific Blood Transfusion 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Numerous Oncologists Are Concerned About the Cost of Genomic Testing.

2.

According to new studies, some cancer patients can safely forego radiation therapy.

3.

TRK Inhibitor Active in Treatment-Refractory Glioblastoma

4.

Guidelines for cervical cancer screening and the risk of preterm birth in young women.

5.

Pretreatment Liver Tests Often Overlooked in CDK4/6 Therapy

1.

Understanding Thrombin Time: What It Is and How It Can Help Diagnose Blood Clotting Disorders

2.

Biomimetic Nanovesicles for Breast Cancer: Targeting Senescence to Overcome Chemoresistance

3.

Chemotherapy Advances: Albumin I.V., Trastuzumab, Liposomal Doxorubicin & More

4.

Integrating Immunotherapy and Staging Guidelines in Lung Cancer Treatment

5.

Unveiling the Mystery Behind Lymphovascular Invasion

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment

2.

Redefining Treatment Pathways in Relapsed/Refractory Adult B-Cell ALL

3.

Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC

4.

A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC

5.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part III

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot